Interestingly, bigenic expression of activated MMTV-Neu and constitutively active Akt1 under MMTV promoter results in accelerated tumor onset but suppressed metastasis [134], implicating that the malignancy-promoting function of Akt1 in mammary cancer is mainly targeting the primary tumor. Here, ERBB2 is linked to breast cancer.